Alk-Abello AS (LTS:0OIR) Other Financing: kr-19 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0OIR Alk-Abello AS LTS:0OIR
93 GF Score
Price kr149.45
GF Value kr151.85
Valuation Fairly Valued
View Full Analysis

What is Alk-Abello AS Other Financing?

Alk-Abello AS LTS:0OIR 93 Other Financing is kr-19 Mil as of Mar. 2026. GuruFocus rates LTS:0OIR with a GF Score™ of 93/100 and a GF Value™ of kr151.85 (Fairly Valued).

Alk-Abello AS's Other Financing for the three months ended in Mar. 2026 was kr0 Mil.

Alk-Abello AS's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was kr-19 Mil.

Alk-Abello AS Other Financing Historical Data

* Premium members only.

The historical data trend for Alk-Abello AS's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alk-Abello AS Other Financing Chart

Alk-Abello AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Alk-Abello AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -19.00 0.00
LTS:0OIR
93GF Score
Alk-Abello AS LTS:0OIR
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alk-Abello AS Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of kr-19 Mil mean?
Alk-Abello AS (LTS:0OIR) has a Other Financing of kr-19 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Alk-Abello AS and its competitors.
Is Alk-Abello AS's Other Financing too high?
Alk-Abello AS's current Other Financing is kr-19 Mil. Overall, Alk-Abello AS has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Alk-Abello AS's Other Financing compare to VRTX and REGN?
Alk-Abello AS's Other Financing of kr-19 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Alk-Abello AS and its competitors. Alk-Abello AS's current Other Financing is kr-19 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alk-Abello AS stock overvalued right now?
Based on GuruFocus' analysis, Alk-Abello AS (LTS:0OIR) is currently considered Fairly Valued. The stock's GF Value™ is kr151.85, compared to a current price of kr149.45 — trading 1.6% below its estimated fair value. The current Other Financing is kr-19 Mil. Alk-Abello AS's overall GF Score™ is 93/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Alk-Abello AS (LTS:0OIR), the current Other Financing is kr-19 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alk-Abello AS (LTS:0OIR) Overvalued in 2026?

Based on GuruFocus' analysis, Alk-Abello AS stock appears to be undervalued. The current stock price of kr149.45 is trading 1.6% below its estimated GF Value™ of kr151.85. GuruFocus considers Alk-Abello AS to be Fairly Valued.

Key valuation signals for LTS:0OIR:

  • Other Financing: kr-19 Mil
  • GF Value™: kr151.85 vs. price of kr149.45 (1.6% below fair value)
  • GF Score™: 93/100

No single metric tells the full story. See the LTS:0OIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alk-Abello AS Business Description

Address Boge Alle 6-8, Horsholm, DNK, DK-2970
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.
93GF Score

Get the complete analysis for LTS:0OIR

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr149.45
Price
kr151.85
GF Value